Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.

Schadt L, Sparano C, Schweiger NA, Silina K, Cecconi V, Lucchiari G, Yagita H, Guggisberg E, Saba S, Nascakova Z, Barchet W, van den Broek M.

Cell Rep. 2019 Oct 29;29(5):1236-1248.e7. doi: 10.1016/j.celrep.2019.09.065.

2.

Editorial: Immune Outposts on the Inflammatory Frontier: Tertiary Lymphoid Structures as Targets for Immunotherapy of Cancer and Autoimmunity.

Silina K, Kroeger D.

Front Immunol. 2019 May 3;10:993. doi: 10.3389/fimmu.2019.00993. eCollection 2019. No abstract available.

3.

A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer.

Wagner J, Rapsomaniki MA, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, Rees M, Ramaswamy A, Muenst S, Soysal SD, Jacobs A, Windhager J, Silina K, van den Broek M, Dedes KJ, Rodríguez Martínez M, Weber WP, Bodenmiller B.

Cell. 2019 May 16;177(5):1330-1345.e18. doi: 10.1016/j.cell.2019.03.005. Epub 2019 Apr 11.

4.

Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer.

Garaud S, Zayakin P, Buisseret L, Rulle U, Silina K, de Wind A, Van den Eyden G, Larsimont D, Willard-Gallo K, Linē A.

Front Immunol. 2018 Nov 20;9:2660. doi: 10.3389/fimmu.2018.02660. eCollection 2018.

5.

A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures.

Siliņa K, Burkhardt C, Casanova R, Solterman A, van den Broek M.

Methods Mol Biol. 2018;1845:71-86. doi: 10.1007/978-1-4939-8709-2_5.

PMID:
30141008
6.

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer.

Posch F, Silina K, Leibl S, Mündlein A, Moch H, Siebenhüner A, Samaras P, Riedl J, Stotz M, Szkandera J, Stöger H, Pichler M, Stupp R, van den Broek M, Schraml P, Gerger A, Petrausch U, Winder T.

Oncoimmunology. 2017 Dec 18;7(2):e1378844. doi: 10.1080/2162402X.2017.1378844. eCollection 2018.

7.

Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.

Siliņa K, Soltermann A, Attar FM, Casanova R, Uckeley ZM, Thut H, Wandres M, Isajevs S, Cheng P, Curioni-Fontecedro A, Foukas P, Levesque MP, Moch H, Linē A, van den Broek M.

Cancer Res. 2018 Mar 1;78(5):1308-1320. doi: 10.1158/0008-5472.CAN-17-1987. Epub 2017 Dec 26.

8.

The Prevalence of Cancer-Associated Autoantibodies in Patients with Gastric Cancer and Progressive Grades of Premalignant Lesions.

Meistere I, Werner S, Zayakin P, Siliņa K, Rulle U, Pismennaja A, Šantare D, Kikuste I, Isajevs S, Leja M, Kupčinskas L, Kupčinskas J, Jonaitis L, Wu CY, Brenner H, Linē A, Kalniņa Z.

Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1564-1574. doi: 10.1158/1055-9965.EPI-17-0238. Epub 2017 Aug 2.

9.

An Immune Atlas of Clear Cell Renal Cell Carcinoma.

Chevrier S, Levine JH, Zanotelli VRT, Silina K, Schulz D, Bacac M, Ries CH, Ailles L, Jewett MAS, Moch H, van den Broek M, Beisel C, Stadler MB, Gedye C, Reis B, Pe'er D, Bodenmiller B.

Cell. 2017 May 4;169(4):736-749.e18. doi: 10.1016/j.cell.2017.04.016.

10.

Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced Cancer.

Bransi A, Salgado OC, Beffinger M, Milo K, Silina K, Yagita H, Becher B, Knuth A, van den Broek M.

Cancer Immunol Res. 2015 Nov;3(11):1279-88. doi: 10.1158/2326-6066.CIR-15-0103-T. Epub 2015 Jul 3.

11.

High Reproducibility of ELISPOT Counts from Nine Different Laboratories.

Sundararaman S, Karulin AY, Ansari T, BenHamouda N, Gottwein J, Laxmanan S, Levine SM, Loffredo JT, McArdle S, Neudoerfl C, Roen D, Silina K, Welch M, Lehmann PV.

Cells. 2015 Jan 9;4(1):21-39. doi: 10.3390/cells4010021.

12.

Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.

Ivanova L, Zandberga E, Siliņa K, Kalniņa Z, Ābols A, Endzeliņš E, Vendina I, Romanchikova N, Hegmane A, Trapencieris P, Eglītis J, Linē A.

Cancer Chemother Pharmacol. 2015 Feb;75(2):235-46. doi: 10.1007/s00280-014-2635-1. Epub 2014 Nov 25.

PMID:
25422154
13.

Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.

Abols A, Ducena K, Zayakin P, Silina K, Kalnina Z, Sadovska L, Tars J, Vilmanis J, Narbuts Z, Eglitis J, Pirags V, Line A.

Cancer Biomark. 2014;14(5):361-9. doi: 10.3233/CBM-140413.

PMID:
25171478
14.

Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?

Siliņa K, Rulle U, Kalniņa Z, Linē A.

Cancer Immunol Immunother. 2014 Jul;63(7):643-62. doi: 10.1007/s00262-014-1544-9. Epub 2014 Apr 3. Review.

PMID:
24695950
15.

Tumor-associated autoantibody signature for the early detection of gastric cancer.

Zayakin P, Ancāns G, Siliņa K, Meistere I, Kalniņa Z, Andrejeva D, Endzeliņš E, Ivanova L, Pismennaja A, Ruskule A, Doniņa S, Wex T, Malfertheiner P, Leja M, Linē A.

Int J Cancer. 2013 Jan 1;132(1):137-47. doi: 10.1002/ijc.27667. Epub 2012 Jul 3.

16.

Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients.

Siliņa K, Zayakin P, Kalniņa Z, Ivanova L, Meistere I, Endzeliņš E, Abols A, Stengrēvics A, Leja M, Ducena K, Kozirovskis V, Linē A.

J Immunother. 2011 Jan;34(1):28-44. doi: 10.1097/CJI.0b013e3181fb64fa.

PMID:
21150711
17.

Effects of lycopene, indole-3-carbinol, and luteolin on nitric oxide production and iNOS expression are organ-specific in rats.

Rostoka E, Isajevs S, Baumane L, Line A, Silina K, Dzintare M, Sharipova J, Svirina D, Kalvinsh I, Sjakste N.

Arh Hig Rada Toksikol. 2010 Sep;61(3):275-85. doi: 10.2478/10004-1254-61-2010-2012.

PMID:
20860968
18.

Effects of kaempferol and myricetin on inducible nitric oxide synthase expression and nitric oxide production in rats.

Rostoka E, Baumane L, Isajevs S, Line A, Dzintare M, Svirina D, Sharipova J, Silina K, Kalvinsh I, Sjakste N.

Basic Clin Pharmacol Toxicol. 2010 Jun;106(6):461-6. doi: 10.1111/j.1742-7843.2009.00526.x. Epub 2010 Jan 18. Erratum in: Basic Clin Pharmacol Toxicol. 2011 Jun;108(6):436.

19.

ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring--even in hands of ELISPOT-inexperienced investigators.

Zhang W, Caspell R, Karulin AY, Ahmad M, Haicheur N, Abdelsalam A, Johannesen K, Vignard V, Dudzik P, Georgakopoulou K, Mihaylova A, Silina K, Aptsiauri N, Adams V, Lehmann PV, McArdle S.

J Immunotoxicol. 2009 Dec;6(4):227-34. doi: 10.3109/15476910903317546.

PMID:
19908941
20.

Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.

Kalnina Z, Silina K, Bruvere R, Gabruseva N, Stengrevics A, Barnikol-Watanabe S, Leja M, Line A.

Eur J Histochem. 2009 Jan-Mar;53(1):7-18.

21.

Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.

Kalnina Z, Silina K, Bruvere R, Gabruseva N, Stengrevics A, Barnikol-Watanabe S, Leja M, Line A.

Eur J Histochem. 2009 Mar 31;53(1):e2. doi: 10.4081/ejh.2009.e2. eCollection 2009 Mar 31. Review.

22.

Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.

Kalniņa Z, Siliņa K, Meistere I, Zayakin P, Rivosh A, Abols A, Leja M, Minenkova O, Schadendorf D, Linē A.

J Immunol Methods. 2008 May 20;334(1-2):37-50. doi: 10.1016/j.jim.2008.01.022. Epub 2008 Feb 21.

PMID:
18314130
23.

Alterations of pre-mRNA splicing in cancer.

Kalnina Z, Zayakin P, Silina K, Linē A.

Genes Chromosomes Cancer. 2005 Apr;42(4):342-57. Review.

PMID:
15648050
25.
26.

Characterisation of tumour-associated antigens in colon cancer.

Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC.

Cancer Immunol Immunother. 2002 Nov;51(10):574-82. Epub 2002 Sep 19.

PMID:
12384809
27.

Supplemental Content

Loading ...
Support Center